Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia-Reference-Cited by-同舟云学术

Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia

Published:2020-12-03 Issue:2 Volume:64 Page:144-151
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Segrelles‐Calvo Gonzalo¹²,Araújo Glauber R. S.³,Llopis‐Pastor Estefanía¹,Carrillo Javier¹⁴,Hernández‐Hernández Marta¹,Rey Laura¹,Rodríguez Melean Nestor¹,Escribano Inés¹²,Antón Esther¹,Zamarro Celia¹,García‐Salmones Mercedes¹⁴,Frases Susana³^ORCID

Affiliation:

1. Servicio de Neumología Hospital Universitario Rey Juan Carlos Madrid España

2. Instituto de Investigación Biomédica Fundación Jiménez Díaz Madrid España

3. Laboratório de Biofísica de Fungos Instituto de Biofísica Carlos Chagas Filho Universidade Federal do Rio de Janeiro Rio de Janeiro Brasil

4. Servicio de Neumología Hospital Universitario Infanta Elena Madrid España

Funder

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13219

Reference33 articles.

1. Hidden Killers: Human Fungal Infections

2. DasR.An overview of changing trends in systemic fungal infections. Published online2012;http://www.webmedcentral.com/article_view/3375URL:http://www.webmedcentral.com/article_view/3386

3. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

4. Pulmonary pathology of severe acute respiratory syndrome in Toronto

5. Confirmed invasive pulmonary aspergillosis and COVID‐19: the value of postmortem findings to support antemortem management;Santana MF;Rev Soc Bras Med Trop,2020

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography signs of the possible aspergillosis in the dynamic observation of patients with COVID-19;Journal of Clinical Practice;2024-04-17

2. Nanotherapeutics for the Delivery of Antifungal Drugs;Therapeutic Delivery;2024-01

3. Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects;Science of The Total Environment;2023-12

4. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA;Frontiers in Cellular and Infection Microbiology;2023-11-21

5. Diagnosis of invasive pulmonary aspergillosis by lateral flow assay of galactomannan in bronchoalveolar lavage fluid: a meta-analysis of diagnostic performance;Letters in Applied Microbiology;2023-09-28